journal article·2023-09-13

Deep Tumor Penetration of CRISPR-Cas System for Photothermal-Sensitized Immunotherapy via Probiotics

Wen Luo, Zhibin Zhang, Dongtao Zhou, Yateng Jiang, Jingjing Yang, Bangshun He, Haijia Yu, Yujun Song

Nano Letters· Volume 23· Issue 17
Publisher page

Abstract

Since central cells are more malignant and aggressive in solid tumors, improving penetration of therapeutic agents and activating immunity in tumor centers exhibit great potential in cancer therapies. Here, polydopamine-coated Escherichia coli Nissle 1917 (EcN) bearing CRISPR-Cas9 plasmid-loaded liposomes (Lipo-P) are applied for enhanced immunotherapy in deep tumors through activation of innate and adaptive immunity simultaneously. After accumulation in the tumor center through hypoxia targeting, Lipo-P could be detached under the reduction of reactive oxygen species (ROS)-responsive linkers, lowering the thermal resistance of cancer cells via Hsp90α depletion. Owing to that, heating induced by polydopamine upon near-infrared irradiation could achieve effective tumor ablation. Furthermore, mild photothermal therapy induces immunogenic cell death, as bacterial infections in tumor tissues trigger innate immunity. This bacteria-assisted approach provides a promising photothermal-sensitized immunotherapy in deep tumors.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Cancer Research and Treatments · Nanoplatforms for cancer theranostics · Virus-based gene therapy research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Jiangsu Key Laboratory of Artificial Functional Materials, State Key Laboratory of Analytical Chemistry for Life Science, National Laboratory of Solid State Microstructures, College of Engineering and Applied Sciences, Nanjing University, Nanjing 210023, China

Department of Biochemistry and Molecular Biology, School of Medicine & Holistic Integrative Medicine, Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, Nanjing University of Chinese Medicine, Nanjing 210023, China

Department of Laboratory Medicine, Nanjing First Hospital, 210006, Nanjing, China

The Jiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing 210023, China

Funding

Jiangsu Provincial Key Research and Development Program · Graduate Research and Innovation Projects of Jiangsu Province · National Key Research and Development Program of China · Natural Science Foundation of Jiangsu Province · High Level Innovation and Entrepreneurial Research Team Program in Jiangsu · Fundamental Research Funds for the Central Universities · National Natural Science Foundation of China

References (57)

Show source-provided references
1. 10.1126/science.342.6165.143210.1126/science.342.6165.1432 ↗
2. 10.1038/s41568-022-00491-010.1038/s41568-022-00491-0 ↗
3. 10.1038/s41590-021-00940-210.1038/s41590-021-00940-2 ↗
4. 10.1038/s41586-019-1836-510.1038/s41586-019-1836-5 ↗
5. 10.1038/nrclinonc.2013.208-c210.1038/nrclinonc.2013.208-c2 ↗
6. 10.1038/s41467-021-22033-210.1038/s41467-021-22033-2 ↗
7. 10.1002/adma.20220805910.1002/adma.202208059 ↗
8. 10.1002/adma.20220747110.1002/adma.202207471 ↗
9. 10.1016/j.bioactmat.2021.12.03310.1016/j.bioactmat.2021.12.033 ↗
10. 10.1002/adhm.20220139910.1002/adhm.202201399 ↗
11. 10.1038/s41563-022-01251-z10.1038/s41563-022-01251-z ↗
12. 10.1021/acsnano.2c1176410.1021/acsnano.2c11764 ↗
13. 10.1021/jacs.1c0307110.1021/jacs.1c03071 ↗
14. 10.1038/s41559-021-01456-610.1038/s41559-021-01456-6 ↗
15. 10.1126/science.aat501110.1126/science.aat5011 ↗
16. 10.1073/pnas.190469711610.1073/pnas.1904697116 ↗
17. 10.1002/anie.20170868910.1002/anie.201708689 ↗
18. 10.1002/adma.20200600310.1002/adma.202006003 ↗
19. 10.1038/s41565-022-01122-310.1038/s41565-022-01122-3 ↗
20. 10.1126/sciadv.abb400510.1126/sciadv.abb4005 ↗
21. 10.1002/anie.20210703610.1002/anie.202107036 ↗
22. 10.3389/fcell.2021.67446710.3389/fcell.2021.674467 ↗
23. 10.1038/nbt.308110.1038/nbt.3081 ↗
24. 10.1038/s41565-019-0539-210.1038/s41565-019-0539-2 ↗
25. 10.1002/adma.20190257510.1002/adma.201902575 ↗
26. 10.1021/jacs.7b1175410.1021/jacs.7b11754 ↗
27. 10.1126/sciadv.aav719910.1126/sciadv.aav7199 ↗
28. 10.1002/anie.20171308210.1002/anie.201713082 ↗
29. 10.1038/nrc306410.1038/nrc3064 ↗
30. 10.1038/nrc189310.1038/nrc1893 ↗
31. 10.1038/onc.2016.22510.1038/onc.2016.225 ↗
32. 10.1021/acsnano.7b0208210.1021/acsnano.7b02082 ↗
33. 10.1021/acsnano.7b0320710.1021/acsnano.7b03207 ↗
34. 10.1002/advs.20210580710.1002/advs.202105807 ↗
35. 10.1038/s41467-021-26367-910.1038/s41467-021-26367-9 ↗
36. 10.1093/toxsci/kfi31610.1093/toxsci/kfi316 ↗
37. 10.1158/0008-5472.CAN-06-261810.1158/0008-5472.CAN-06-2618 ↗
38. 10.1126/sciadv.aba354610.1126/sciadv.aba3546 ↗
39. 10.1021/acsnano.0c0806810.1021/acsnano.0c08068 ↗
40. 10.1002/advs.20200357210.1002/advs.202003572 ↗
41. 10.1021/acs.nanolett.5b0057010.1021/acs.nanolett.5b00570 ↗
42. 10.1016/j.cell.2016.03.00110.1016/j.cell.2016.03.001 ↗
43. 10.1038/nri100410.1038/nri1004 ↗
44. 10.1111/1348-0421.1233310.1111/1348-0421.12333 ↗
45. 10.1038/s41568-018-0070-z10.1038/s41568-018-0070-z ↗
46. 10.1038/nnano.2016.13710.1038/nnano.2016.137 ↗
47. 10.1021/nn501130410.1021/nn5011304 ↗
48. 10.1038/s41467-018-03233-910.1038/s41467-018-03233-9 ↗
49. 10.1038/s41467-021-26956-810.1038/s41467-021-26956-8 ↗
50. 10.1002/anie.20220240910.1002/anie.202202409 ↗
51. 10.1002/adma.20120468310.1002/adma.201204683 ↗
52. 10.1016/j.biomaterials.2009.02.01810.1016/j.biomaterials.2009.02.018 ↗
53. 10.1002/adfm.20201063710.1002/adfm.202010637 ↗
54. 10.1021/acsnano.8b0223510.1021/acsnano.8b02235 ↗
55. 10.1002/anie.20220842210.1002/anie.202208422 ↗
56. 10.1002/adma.20170440810.1002/adma.201704408 ↗
57. 10.1615/CritRevBiomedEng.v34.i6.2010.1615/CritRevBiomedEng.v34.i6.20 ↗